RecruitingPhase 2Drug trialTrial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent TreatmentTo investigate the efficacy of AMB-05X in patients with CRC with MRD as determined by a ctDNA(+) blood test and no clinically detectable radiographic disease.